|
PAXIP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
3.45430017922865E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62492241884138E-12 |
| Stage1-vs-Stage2 |
1.434960E-01 |
| Stage1-vs-Stage3 |
5.499400E-01 |
| Stage1-vs-Stage4 |
3.136000E-01 |
| Stage2-vs-Stage3 |
1.192380E-01 |
| Stage2-vs-Stage4 |
6.841900E-02 |
| Stage3-vs-Stage4 |
6.543800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
8.02520000453555E-08 |
| Normal-vs-Asian |
6.99440505513849E-15 |
| Caucasian-vs-AfricanAmerican |
3.794800E-01 |
| Caucasian-vs-Asian |
9.438200E-01 |
| AfricanAmerican-vs-Asian |
4.337800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
9.952000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.27589999998623E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.076000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.811000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.329000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.649400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.294200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.876600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.316740E-03 |
| Classical-VS-Follicular |
7.290000E-01 |
| Classical-VS-Other |
8.530200E-01 |
| Classical-VS-Normal |
1.63880020664919E-12 |
| Tall-VS-Follicular |
1.884000E-02 |
| Tall-VS-Other |
4.062200E-01 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
9.675600E-01 |
| Follicular-VS-Normal |
1.66056057793185E-12 |
| Other-VS-Normal |
3.755000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.219020E-01 |
|
|
